AGP Executive Report
Last update: 3 hours agoImported Malaria Alert: Macau confirmed its first imported malaria case of the year—a 47-year-old man who traveled to Nigeria, developed fever and diarrhoea after returning, and is now hospitalised in serious condition. Cross-Border Care: Macau’s health e-vouchers (700 patacas) are set to work in Guangdong again starting June 1, extending access for eligible residents for two years. Big-Health Dealmaking: Bristol Myers Squibb and Hengrui Pharma signed a collaboration worth up to $15.2B to co-develop 13 early-stage oncology, hematology and immunology programs—relevant to Macau through Hengrui’s Greater China rights. Infection Watch: Macau also reported a sharp April mosquito breeding uptick, raising dengue and chikungunya risk, while a separate Legionnaires’ disease case brought the year’s total to six. Regional Health Hubs: Hong Kong’s embodied AI summit and International Healthcare Week opened this week, pushing AI and innovation into real-world healthcare deployment.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
![<![CDATA[Bristol Myers Squibb, Hengrui Pharma Form $15.2 Billion Strategic Drug Development Collaboration]]>](https://cdn.sanity.io/images/0vv8moc6/pharmexec/92b02a7f6e0c466c155a40ec32a74d94a075d09b-1280x720.jpg)
